heparin + fondaparinux + vitamin K antagonists + aspirin

This is a combination of multiple anticoagulant and antiplatelet medications. It includes heparin (an anticoagulant that inhibits thrombin formation and factor Xa activity), fondaparinux (a synthetic anticoagulant that specifically inhibits factor Xa), vitamin K antagonists (anticoagulants like warfarin that inhibit the synthesis of clotting factors), and aspirin (an antiplatelet that inhibits platelet aggregation). This specific combination is not typically used simultaneously as a standard regimen but represents different antithrombotic agents that might be used in various combinations for specific cardiovascular conditions.

Other names

Anticoagulation for Unsuspected Pulmonary Embolism in Cancer